Determination of 14 circulating microRNAs in Swedes and Iraqis with and without diabetes mellitus type 2

PLoS ONE

Volumn 9, Issue 1, 2014, Pages

  Wang, Xiao ^a   Sundquist, Jan ^a,b   Zöller, Bengt ^a   Memon, Ashfaque A ^a   Palmér, Karolina ^a   Sundquist, Kristina ^a,b   Bennet, Louise ^a  

^a LUND UNIVERSITY   (Sweden)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MICRORNA 126; MICRORNA 144; MICRORNA 150; MICRORNA 15A; MICRORNA 191; MICRORNA 197; MICRORNA 20; MICRORNA 21; MICRORNA 223; MICRORNA 24; MICRORNA 28; MICRORNA 29B; MICRORNA 320A; MICRORNA 486; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; MIRN144 MICRORNA, HUMAN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DEREGULATION; DISEASE ASSOCIATION; ETHNIC DIFFERENCE; FAMILY HISTORY; FEMALE; HIGH RISK PATIENT; HUMAN; IMPAIRED GLUCOSE TOLERANCE; IRAQIS; MAJOR CLINICAL STUDY; MALE; MIDDLE EAST; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOGENESIS; REAL TIME POLYMERASE CHAIN REACTION; SEDENTARY LIFESTYLE; SWEDES; WAIST CIRCUMFERENCE; BLOOD; CASE CONTROL STUDY; ETHNOLOGY; INSULIN RESISTANCE; IRAQ; MIDDLE AGED; SWEDEN; URBAN POPULATION;

AGED; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; INSULIN RESISTANCE; IRAQ; MALE; MICRORNAS; MIDDLE AGED; SWEDEN; URBAN POPULATION;

EID: 84900391930     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0086792     Document Type: Article

References (45)

1. Zimmet P, Magliano D, Matsuzawa Y, Alberti G, Shaw J (2005) The metabolic syndrome: a global public health problem and a new definition. J Atheroscler Thromb 12: 295-300.
2. Wandell PE, Johansson SE, Gafvels C, Hellenius ML, de Faire U, et al. (2008) Estimation of diabetes prevalence among immigrants from the Middle East in Sweden by using three different data sources. Diabetes Metab 34: 328-333.
3. Glans F, Elgzyri T, Shaat N, Lindholm E, Apelqvist J, et al. (2008) Immigrants from the Middle-East have a different form of Type 2 diabetes compared with Swedish patients. Diabet Med 25: 303-307. (Pubitemid 351322704)
4. McCarthy MI, Zeggini E (2009) Genome-wide association studies in type 2 diabetes. Curr Diab Rep 9: 164-171.
5. Sladek R, Rocheleau G, Rung J, Dina C, Shen L, et al. (2007) A genome-wide association study identifies novel risk loci for type 2 diabetes. Nature 445: 881-885.
6. Lango H, Palmer CN, Morris AD, Zeggini E, Hattersley AT, et al. (2008) Assessing the combined impact of 18 common genetic variants of modest effect sizes on type 2 diabetes risk. Diabetes 57: 3129-3135.
7. Guay C, Regazzi R (2013) Circulating microRNAs as novel biomarkers for diabetes mellitus. Nat Rev Endocrinol.
8. Wang Y, Russell I, Chen C (2009) MicroRNA and stem cell regulation. Curr Opin Mol Ther 11: 292-298.
9. Weber JA, Baxter DH, Zhang S, Huang DY, Huang KH, et al. (2010) The microRNA spectrum in 12 body fluids. Clin Chem 56: 1733-1741.
10. Gibbings DJ, Ciaudo C, Erhardt M, Voinnet O (2009) Multivesicular bodies associate with components of miRNA effector complexes and modulate miRNA activity. Nat Cell Biol 11: 1143-1149.
11. Arroyo JD, Chevillet JR, Kroh EM, Ruf IK, Pritchard CC, et al. (2011) Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma. Proc Natl Acad Sci U S A 108: 5003-5008.
12. Vickers KC, Palmisano BT, Shoucri BM, Shamburek RD, Remaley AT (2011) MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins. Nat Cell Biol 13: 423-433.
13. Mathivanan S, Ji H, Simpson RJ (2010) Exosomes: extracellular organelles important in intercellular communication. J Proteomics 73: 1907-1920.
14. Valadi H, Ekstrom K, Bossios A, Sjostrand M, Lee JJ, et al. (2007) Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol 9: 654-659. (Pubitemid 47214727)
15. Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, et al. (2008) Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A 105: 10513-10518.
16. Chen X, Ba Y, Ma L, Cai X, Yin Y, et al. (2008) Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res 18: 997-1006.
17. Pandey AK, Agarwal P, Kaur K, Datta M (2009) MicroRNAs in diabetes: tiny players in big disease. Cell Physiol Biochem 23: 221-232.
18. Kong L, Zhu J, Han W, Jiang X, Xu M, et al. (2011) Significance of serum microRNAs in pre-diabetes and newly diagnosed type 2 diabetes: a clinical study. Acta Diabetol 48: 61-69.
19. Zampetaki A, Kiechl S, Drozdov I, Willeit P, Mayr U, et al. (2010) Plasma microRNA profiling reveals loss of endothelial miR-126 and other microRNAs in type 2 diabetes. Circ Res 107: 810-817.
20. Karolina DS, Tavintharan S, Armugam A, Sepramaniam S, Pek SL, et al. (2012) Circulating miRNA profiles in patients with metabolic syndrome. J Clin Endocrinol Metab 97: E2271-2276.
21. Karolina DS, Armugam A, Tavintharan S, Wong MT, Lim SC, et al. (2011) MicroRNA 144 impairs insulin signaling by inhibiting the expression of insulin receptor substrate 1 in type 2 diabetes mellitus. PLoS One 6: e22839.
22. Bennet L, Johansson SE, Agardh CD, Groop L, Sundquist J, et al. (2011) High prevalence of type 2 diabetes in Iraqi and Swedish residents in a deprived Swedish neighbourhood - a population based study. BMC Public Health 11: 303.
23. Bener A, Zirie M, Al-Rikabi A (2005) Genetics, obesity, and environmental risk factors associated with type 2 diabetes. Croat Med J 46: 302-307. (Pubitemid 40686512)
24. Sun LL, Jiang BG, Li WT, Zou JJ, Shi YQ, et al. (2011) MicroRNA-15a positively regulates insulin synthesis by inhibiting uncoupling protein-2 expression. Diabetes Res Clin Pract 91: 94-100.
25. Ling HY, Hu B, Hu XB, Zhong J, Feng SD, et al. (2012) MiRNA-21 reverses high glucose and high insulin induced insulin resistance in 3T3-L1 adipocytes through targeting phosphatase and tensin homologue. Exp Clin Endocrinol Diabetes 120: 553-559.
26. Feng B, Chakrabarti S (2012) miR-320 Regulates Glucose-Induced Gene Expression in Diabetes. ISRN Endocrinol 2012: 549875.
27. Lu H, Buchan RJ, Cook SA (2010) MicroRNA-223 regulates Glut4 expression and cardiomyocyte glucose metabolism. Cardiovasc Res 86: 410-420.
28. WMA (2008) Declaration of Helsinki - Ethical principles of medical research involving human subjects.
29. Kirschner MB, Kao SC, Edelman JJ, Armstrong NJ, Vallely MP, et al. (2011) Haemolysis during sample preparation alters microRNA content of plasma. PLoS ONE 6: e24145.
30. Pritchard CC, Kroh E, Wood B, Arroyo JD, Dougherty KJ, et al. (2012) Blood cell origin of circulating microRNAs: a cautionary note for cancer biomarker studies. Cancer Prev Res (Phila) 5: 492-497.
31. Gidlof O, Smith JG, Miyazu K, Gilje P, Spencer A, et al. (2013) Circulating cardio-enriched microRNAs are associated with long-term prognosis following myocardial infarction. BMC Cardiovasc Disord 13: 12.
32. Blondal T, Jensby Nielsen S, Baker A, Andreasen D, Mouritzen P, et al. (2013) Assessing sample and miRNA profile quality in serum and plasma or other biofluids. Methods 59: S1-6.
33. Song J, Bai Z, Han W, Zhang J, Meng H, et al. (2012) Identification of suitable reference genes for qPCR analysis of serum microRNA in gastric cancer patients. Dig Dis Sci 57: 897-904.
34. Bye A, Rosjo H, Aspenes ST, Condorelli G, Omland T, et al. (2013) Circulating microRNAs and aerobic fitness - the HUNT-Study. PLoS One 8: e57496.
35. Mestdagh P, Van Vlierberghe P, De Weer A, Muth D, Westermann F, et al. (2009) A novel and universal method for microRNA RT-qPCR data normalization. Genome Biol 10: R64.
36. Kosaka N, Iguchi H, Yoshioka Y, Takeshita F, Matsuki Y, et al. (2010) Secretory mechanisms and intercellular transfer of microRNAs in living cells. J Biol Chem 285: 17442-17452.
37. Laterza OF, Lim L, Garrett-Engele PW, Vlasakova K, Muniappa N, et al. (2009) Plasma MicroRNAs as sensitive and specific biomarkers of tissue injury. Clin Chem 55: 1977-1983.
38. Bovell LC, Shanmugam C, Putcha BD, Katkoori VR, Zhang B, et al. (2013) The Prognostic Value of MicroRNAs Varies with Patient Race/Ethnicity and Stage of Colorectal Cancer. Clin Cancer Res 19: 3955-3965.
39. Park SY, Jeong HJ, Yang WM, Lee W (2013) Implications of microRNAs in the pathogenesis of diabetes. Arch Pharm Res 36: 154-166.
40. Zhang L, Hou D, Chen X, Li D, Zhu L, et al. (2012) Exogenous plant MIR168a specifically targets mammalian LDLRAP1: evidence of cross-kingdom regulation by microRNA. Cell Res 22: 107-126.
41. Faskunger J, Eriksson U, Johansson SE, Sundquist K, Sundquist J (2009) Risk of obesity in immigrants compared with Swedes in two deprived neighbourhoods. BMC Public Health 9: 304.
42. Jonsson LS, Palmer K, Ohlsson H, Sundquist J, Sundquist K (2013) Is acculturation associated with physical activity among female immigrants in Sweden? J Public Health (Oxf) 35: 270-277.
43. Radom-Aizik S, Zaldivar F Jr, Oliver S, Galassetti P, Cooper DM (2010) Evidence for microRNA involvement in exercise-associated neutrophil gene expression changes. J Appl Physiol 109: 252-261.
44. Kim YJ, Hwang SH, Lee SY, Shin KK, Cho HH, et al. (2012) miR-486-5p induces replicative senescence of human adipose tissue-derived mesenchymal stem cells and its expression is controlled by high glucose. Stem Cells Dev 21: 1749-1760.
45. Rutanen J, Yaluri N, Modi S, Pihlajamaki J, Vanttinen M, et al. (2010) SIRT1 mRNA expression may be associated with energy expenditure and insulin sensitivity. Diabetes 59: 829-835.